Muscular Strength in Risk Factors for Cardiovascular Disease and Mortality: A Narrative Review

被引:10
|
作者
Lopez-Jaramillo, Patricio [1 ,2 ]
Lopez-Lopez, Jose P. [1 ,2 ,3 ]
Camila Tole, Maria [1 ]
Cohen, Daniel D. [1 ,2 ]
机构
[1] Univ Santander UDES, Masira Res Inst, Med Sch, Bucaramanga, Colombia
[2] Ctr Integral Prevenc Enfermedades Cardiometab, Floridablanca, Colombia
[3] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Cardiol Unit, Bogota, Colombia
来源
ANATOLIAN JOURNAL OF CARDIOLOGY | 2022年 / 26卷 / 08期
关键词
Muscular strength; hand grip; cardiovascular disease; cardiovascular risk factors; chronic diseases; mortality; hypertension; predictors; prevention; diabetes mellitus; GRIP STRENGTH; METABOLIC SYNDROME; HANDGRIP STRENGTH; BLOOD-PRESSURE; CARDIORESPIRATORY FITNESS; INCIDENT HYPERTENSION; MUSCLE STRENGTH; RESISTANCE; ASSOCIATION; POPULATION;
D O I
10.5152/AnatolJCardiol.2022.1586
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is the leading cause of death globally, accounting for approximately 32% of all deaths in 2019. There has been increasing interest in understanding the role of low muscular strength as a risk factor for cardiovascular disease, given its association with other cardiovascular risk factors such as hypertension, diabetes mellitus, and metabolic syndrome. An inverse association between muscle strength, chronic disease, all-cause mortality, and cardiovascular-related death has been reported. Recent clinical trials have consistently shown that resistance exercise, which increases strength, and potentially muscle mass, significantly improves the control of known cardiovascular disease risk factors and reduces the risk of all-cause death and cardiovascular mortality. In the present article, we review the growing body of evidence that supports the need for future research to evaluate the potential of handgrip strength as a screening tool for cardiovascular disease and its risk factors in the clinical medical setting, as part of routine care using an affordable handgrip strength device. Moreover, it is crucial to devise large-scale interventions driven by governmental health policies to educate the general population and healthcare professionals about the importance of muscular strengthening activities and to promote access to these activities to improve cardiometabolic health and reduce incidence of cardiovascular disease and mortality.
引用
收藏
页码:598 / 607
页数:10
相关论文
共 50 条
  • [41] Analysing the impact of modifiable risk factors on cardiovascular disease mortality in Brazil
    Gaspar, Renato Simoes
    Rezende, Leandro F. M.
    Laurindo, Francisco Rafael Martins
    [J]. PLOS ONE, 2022, 17 (06):
  • [42] Race/ethnicity, income, major risk factors, and cardiovascular disease mortality
    Thomas, AJ
    Eberly, LE
    Smith, GD
    Neaton, JD
    Stamler, J
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 95 (08) : 1417 - 1423
  • [43] Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy
    Lopez-Jaramillo, Patricio
    Joseph, Philip
    Lopez-Lopez, Jose P.
    Lanas, Fernando
    Avezum, Alvaro
    Diaz, Rafael
    Camacho, Paul A.
    Seron, Pamela
    Oliveira, Gustavo
    Orlandini, Andres
    Rangarajan, Sumathy
    Islam, Shofiqul
    Yusuf, Salim
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (30) : 2841 - 2851
  • [45] Cardiovascular risk factors, mortality, and overweight
    McTigue, Kathleen
    Kuller, Lewis
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11): : 1260 - 1261
  • [46] CARDIOVASCULAR RISK-FACTORS AND MORTALITY
    TONKIN, AM
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1988, 148 (02) : 57 - 58
  • [47] Cardiovascular co-morbidity in patients with rheumatoid arthritis: A narrative review of risk factors, cardiovascular risk assessment and treatment
    Jagpal A.
    Navarro-Millán I.
    [J]. BMC Rheumatology, 2 (1)
  • [48] Lipoprotein(a) in Children and Adolescents: Risk or Causal Factor for Cardiovascular Disease? A Narrative Review
    Capra, Maria Elena
    Biasucci, Giacomo
    Banderali, Giuseppe
    Pederiva, Cristina
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [49] Inclisiran for the Treatment of Hyperlipidemia and for Atherosclerotic Cardiovascular Disease Risk Reduction: A Narrative Review
    Cowart, Kevin
    Singleton, Jerica
    Carris, Nicholas W.
    [J]. CLINICAL THERAPEUTICS, 2023, 45 (11) : 1099 - 1104
  • [50] What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review
    Lykowska-Szuber, Liliana
    Rychter, Anna Maria
    Dudek, Magdalena
    Ratajczak, Alicja Ewa
    Szymczak-Tomczak, Aleksandra
    Zawada, Agnieszka
    Eder, Piotr
    Lesiak, Maciej
    Dobrowolska, Agnieszka
    Krela-Kazmierczak, Iwona
    [J]. NUTRIENTS, 2021, 13 (08)